T-helper 17 cytokines (interleukins 17, 21, 22, and 6, and tumor necrosis factor-α) in patients with alopecia areata: Association with clinical type and severity

International Journal of Dermatology

Volumn 55, Issue 6, 2016, Pages 666-672

  Atwa, Mona A ^a   Youssef, Nahed ^a   Bayoumy, Nervana M ^b  

^a Suez Canal University Faculty of Medicine   (Egypt)

^b KING SAUD UNIVERSITY   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 17; INTERLEUKIN 21; INTERLEUKIN 22; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA; INTERLEUKIN DERIVATIVE; INTERLEUKIN-22; TUMOR NECROSIS FACTOR;

ADULT; ALOPECIA AREATA; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE DURATION; DISEASE SEVERITY ASSESSMENT; FEMALE; HUMAN; MALE; PATHOGENESIS; PRACTICE GUIDELINE; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; PROTEIN FUNCTION; TH17 CELL; ADOLESCENT; BLOOD; CASE CONTROL STUDY; IMMUNOLOGY; SEVERITY OF ILLNESS INDEX; TIME FACTOR; YOUNG ADULT;

ADOLESCENT; ADULT; ALOPECIA AREATA; CASE-CONTROL STUDIES; FEMALE; HUMANS; INTERLEUKIN-17; INTERLEUKIN-6; INTERLEUKINS; MALE; SEVERITY OF ILLNESS INDEX; TH17 CELLS; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA; YOUNG ADULT;

EID: 84938397199     PISSN: 00119059     EISSN: 13654632     Source Type: Journal    
DOI: 10.1111/ijd.12808     Document Type: Article

References (43)

1. Alkhalifah A, Alsantali A, Wang E, et al. Alopecia areata update: part I. Clinical picture, histopathology, and pathogenesis. J Am Acad Dermatol 2010; 62: 177-188.
2. Alkhalifah A, Alsantali A, Wang E, et al. Alopecia areata update: part II Treatment. J Am Acad Dermatol 2010; 62: 191-202.
3. McElwee KJ, Yu M, Park SW, et al. What can we learn from animal models of alopecia areata? Dermatology 2005; 211: 47-53.
4. Gilhar A, Kalish RS. Alopecia areata: a tissue specific autoimmune disease of the hair follicle. Autoimmun Rev 2006; 5: 64-69.
5. Gilhar A, Landau M, Assy B, et al. Transfer of alopecia areata in the human scalp graft/Prkdc (scid) (SCID) mouse system is characterized by a Th1 response. Clin Immunol 2003; 106: 181-187.
6. Barahmani N, Lopez A, Babu D, et al. Serum T helper 1 cytokine levels are greater in patients with alopecia areata regardless of severity or atopy. Clin Exp Dermatol 2010; 35: 409-416.
7. Bettelli E, Oukka M, Kuchroo VK. Th-17 cells in the circle of immunity and autoimmunity. Nat Immunol 2007; 8: 345-350.
8. Harrington LE, Hatton RD, Mangan PR, et al. Interleukin17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineage. Nat Immunol 2005; 6: 1123-1132.
9. Park H, Li Z, Yang XO, et al. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat Immunol 2005; 6: 1133-1141.
10. Liang SC, Tan XY, Luxenberg DP, et al. Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides. J Exp Med 2006; 203: 2271-2279.
11. Ouyang W, Kolls JK, Zheng Y. The biological functions of T helper 17 cell effector cytokines in inflammation. Immunity 2008; 28: 454-467.
12. Wilson NJ, Boniface K, Chan JR, et al. Development, cytokine profile and function of human interleukin 17-producing helper T cells. Nat Immunol 2007; 8: 950-957.
13. Chen Z, Tato CM, Muul L, et al. Distinct regulation of interleukin-17 in human T helper lymphocytes. Arthritis Rheum 2007; 56: 2936-2946.
14. Mangan PR, Harrington LE, O'Quinn DB, et al. Transforming growth factor-beta induces development of the T(H)17 lineage. Nature 2006; 441: 231-234.
15. Lubberts E, Koenders MI, Oppers-Walgreen B, et al. Treatment with a neutralizing anti-murine interleukin-17 antibody after the onset of collagen-induced arthritis reduces joint inflammation, cartilage destruction, and bone erosion. Arthritis Rheum 2004; 50: 650-659.
16. Yen D, Cheung J, Scheerens H, et al. IL-23 is essential for T cell-mediated colitis and promotes inflammation via IL-17 and IL-6. J Clin Invest 2006; 116: 1310-1316.
17. Arican O, Aral M, Sasmaz S, et al. Serum levels of TNF-alpha, IFN-gamma, IL-6, IL-8, IL-12, IL-17, and IL-18 in patients with active psoriasis and correlation with disease severity. Mediators Inflamm 2005; 5: 273-279.
18. Fujino S, Andoh A, Fujiyama Y. Increased expression of interleukin 17 in inflammatory bowel disease. Gut 2003; 52: 65-70.
19. Kawaguchi M, Onuchic LF, Li XD, et al. Identification of a novel cytokine, ML-1, and its expression in subjects with asthma. J Immunol 2001; 167: 4430-4435.
20. Kawaguchi M, Takahashi D, Hizawa N, et al. IL-17F sequence variant (His161Arg) is associated with protection against asthma and antagonizes wildtype IL-17F activity. J Allergy Clin Immunol 2006; 117: 795-801.
21. McAllister F, Henry A, Kreindler JL, et al. Role of IL-17A, IL-17F, and the IL-17 receptor in regulating growth-related oncogene-alpha and granulocyte colony-stimulating factor in bronchial epithelium: implications for airway inflammation in cystic fibrosis. J Immunol 2005; 175: 404-412.
22. Wong CK, Lit LC, Tam LS, et al. Hyperproduction of IL-23 and IL-17 in patients with systemic lupus erythematosus: implications for Th17-mediated inflammation in autoimmunity. Clin Immunol 2008; 127: 385-393.
23. Lew BL, Cho HR, Haw S, et al. Association between IL17A/IL17RA gene polymorphisms and susceptibility to alopecia areata in the Korean population. Ann Dermatol 2012; 24: 61-65.
24. Olsen EA, Hordinsky MK, Price VH, et al. Alopecia areata investigational assessment guideline Part II. J Am Acad Dermatol 2004; 51: 440-447.
25. Cetin ED, Savk E, Uslu M, et al. Investigation of the inflammatory mechanisms in alopecia areata. Am J Dermatopathol 2009; 31: 53-60.
26. Afzali B, Lombardi G, Lechler RI, et al. The role of T helper 17 (Th17) and regulatory T cells (Treg) in human organ transplantation and autoimmune disease. Clin Exp Immunol 2007; 148: 32-46.
27. Tojo G, Fujimura T, Kawano M, et al. Comparison of interleukin-17-producing cells in different clinical types of alopecia areata. Dermatology 2013; 227: 78-82.
28. Tanemura A, Oiso N, Nakano M, et al. Alopecia areata: infiltration of Th17 cells in the dermis, particularly around hair follicles. Dermatology 2013; 226: 333-336.
29. Lock C, Hermans G, Pedotti R, et al. Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis. Nat Med 2002; 8: 500-508.
30. Teunissen MB, Koomen CW, De Waal Malefyt R, et al. Interleukin-17 and interferon-gamma synergize in the enhancement of proinflammatory cytokine production by human keratinocytes. J Invest Dermatol 1998; 111: 645-649.
31. Ziolkowska M, Koc A, Luszczykiewicz G, et al. High levels of IL-17 in rheumatoid arthritis patients: IL-15 triggers in vitro IL-17 production via cyclosporin A-sensitive mechanism. J Immunol 2000; 164: 2832-2838.
32. Tembhre MK, Sharma VK. T-helper and regulatory T-cell cytokines in the peripheral blood of patients with active alopecia areata. Br J Dermatol 2013; 169: 543-548.
33. Brandt K, Singh PB, Bulfone-Paus S, et al. Interleukin 21: a new modulator of immunity, infection and cancer. Cytokine Growth Factor Rev 2007; 18: 223-232.
34. Costanzo A, Chimenti MS, Botti E, et al. IL-21 in the pathogenesis and treatment of skin diseases. J Dermatol Sci 2010; 60: 61-66.
35. Boniface K, Guignouard E, Pedretti N, et al. A role for T cell-derived interleukin-22 in psoriatic skin inflammation. Clin Exp Immunol 2007; 150: 407-415.
36. Ricciardi L, Minciullo PL, Saitta S, et al. Increased serum levels of IL-22 in patients with nickel contact dermatitis. Contact Dermatitis 2009; 60: 57-58.
37. Korn T, Bettelli E, Gao W, et al. IL-21 initiates an alternative pathway to induce proinflammatory Th17 cells. Nature 2007; 448: 484-487.
38. McGeachy MJ, Cua DJ. Th17 cell differentiation: the long and winding road. Immunity 2008; 28: 445-453.
39. Zhou L, Ivanov II, Spolski R, et al. IL-6 programs T(H)-17 cell differentiation by promoting sequential engagement of the IL-21 and IL-23 pathways. Nat Immunol 2007; 8: 967-974.
40. Wan S, Xia C, Morel L. IL-6 produced by dendritic cells from lupus-prone mice inhibits CD4+CD25+ T cell regulatory functions. J Immunol 2007; 178: 271-279.
41. Teraki Y, Imanishi K, Shiohara T. Cytokines in alopecia areata: contrasting cytokine profiles in localized form and extensive form (alopecia universalis). Acta Derm Venereol 1996; 76: 421-423.
42. McElwee KJ, Hoffmann R. Alopecia areata animal models. Clin Exp Dermatol 2002; 27: 410-417.
43. Bodemer C, Peuchmaur M, Fraitaig S, et al. Role of cytotoxic T cells in chronic alopecia areata. J Invest Dermatol 2000; 114: 112-116.